China Defibrillator Market Size & Outlook, 2024-2030
The defibrillator market in China is expected to reach a projected revenue of US$ 549.4 million by 2030. A compound annual growth rate of 9.4% is expected of China defibrillator market from 2024 to 2030.
In terms of revenue, China accounted for 4.0% of the defibrillator market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, Japan defibrillator market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 516.9 million by 2030.
In China, defibrillators can be classified as class III medical devices. This class of medical devices must be approved by the Food and Drug Administration (FDA) of the State Council. To produce such devices, the company must apply for approval from the FDA of the province, municipality under the central government, or autonomous region where it is located.
The validity of such permits is normally for 5 years, although it can be extended with the necessary documentation. The patients using a class III medical device should have proper documentation. China’s ICDs and CRT-D market segment is also expected to grow.
Moreover, government reforms to improve economic conditions and healthcare access will likely boost the medical devices trade and in-house manufacturing. This is anticipated to influence the defibrillators market in China, making it a potential regional market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Defibrillator Market Outlook will help companies and investors design strategic landscapes.
External Defibrillator was the largest segment with a revenue share of 54.05% in 2023.
Horizon Databook has segmented the China defibrillator market based on implantable cardioverter defibrillator (icd), external defibrillator covering the revenue growth of each sub-segment from 2018 to 2030.
In China, defibrillators can be classified as class III medical devices. This class of medical devices must be approved by the Food and Drug Administration (FDA) of the State Council. To produce such devices, the company must apply for approval from the FDA of the province, municipality under the central government, or autonomous region where it is located.
The validity of such permits is normally for 5 years, although it can be extended with the necessary documentation. The patients using a class III medical device should have proper documentation. China’s ICDs and CRT-D market segment is also expected to grow.
Moreover, government reforms to improve economic conditions and healthcare access will likely boost the medical devices trade and in-house manufacturing. This is anticipated to influence the defibrillators market in China, making it a potential regional market.
China Defibrillator Market Product Outlook (Revenue, USD Million , 2018-2030)
Implantable Cardioverter Defibrillator (ICD)
External Defibrillator
China Defibrillator Market end Use Outlook (Revenue, USD Million , 2018-2030)
Hospital
Pre hospital
Public Access market
Alternate care market
Home healthcare
Reasons to subscribe to Defibrillator Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Defibrillator Market Outlook databook
Our clientele includes a mix of Defibrillator Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Defibrillator Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Defibrillator Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.